Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Incyte - 32 Year Stock Price History | INCY

Historical daily share price chart and data for Incyte since 1993 adjusted for splits and dividends. The latest closing stock price for Incyte as of July 11, 2025 is 68.59.
  • The all-time high Incyte stock closing price was 152.66 on March 15, 2017.
  • The Incyte 52-week high stock price is 83.95, which is 22.4% above the current share price.
  • The Incyte 52-week low stock price is 53.56, which is 21.9% below the current share price.
  • The average Incyte stock price for the last 52 weeks is 67.31.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
  
Incyte Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2025 66.6150 69.5300 75.2600 55.1700 68.5900 -0.69%
2024 62.9804 65.4500 83.3800 51.1800 69.0700 10.00%
2023 66.1166 79.5500 86.0100 52.1600 62.7900 -21.83%
2022 74.7658 73.9700 84.1100 66.0200 80.3200 9.43%
2021 77.9284 86.4500 100.5000 63.3400 73.4000 -15.61%
2020 88.8053 85.9700 109.6900 63.1800 86.9800 -0.39%
2019 81.9818 63.5600 95.7200 63.5600 87.3200 37.32%
2018 72.8748 100.8900 100.9800 58.5000 63.5900 -32.86%
2017 121.3776 102.3200 152.6600 93.5600 94.7100 -5.55%
2016 83.5443 103.3200 108.1000 63.0500 100.2700 -7.54%
2015 102.6877 73.7600 131.4700 71.4900 108.4500 48.34%
2014 57.1143 51.2300 78.8900 43.1000 73.1100 44.40%
2013 28.9761 17.0000 51.3400 17.0000 50.6300 204.82%
2012 19.2983 14.9900 25.8400 14.7800 16.6100 10.66%
2011 15.7089 16.5200 20.7600 11.7800 15.0100 -9.36%
2010 13.4671 9.5000 17.1700 9.4100 16.5600 81.78%
2009 4.7656 3.8500 9.4000 2.0500 9.1100 140.37%
2008 8.3997 9.9800 12.4200 2.4900 3.7900 -62.29%
2007 7.1488 6.0200 10.7800 4.8100 10.0500 72.09%
2006 4.8333 5.3400 6.2000 3.5800 5.8400 9.36%
2005 7.1163 9.6400 9.6600 4.2700 5.3400 -46.55%
2004 8.3024 6.8200 10.9600 5.4500 9.9900 46.05%
2003 4.6665 4.9090 6.9100 2.6700 6.8400 50.00%
2002 8.0164 19.4000 19.6900 2.9800 4.5600 -76.54%
2001 18.1807 22.5625 30.6250 10.7600 19.4400 -21.85%
2000 47.9742 44.8281 140.2500 23.5625 24.8750 -17.08%
1999 12.9276 18.5000 31.5625 8.2813 30.0000 60.54%
1998 17.8034 21.3750 25.1875 9.2500 18.6875 -16.94%
1997 16.6613 12.7500 22.5000 10.6250 22.5000 74.76%
1996 9.3198 7.0313 12.8750 6.0625 12.8750 106.00%
1995 4.4126 3.4063 6.2500 3.2813 6.2500 80.18%
1994 2.4208 2.1875 3.9063 1.7188 3.4688 54.17%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $13.277B $4.241B
Incyte Corporation is a biopharmaceutical company focused on the discovery, development and commercialization of proprietary therapeutics. The company conducts its European clinical development operations in Geneva, Switzerland. Incyte's lead drug, Jakafi (ruxolitinib), is a first-in-class JAK1/JAK2 inhibitor, approved in the United States for the treatment of patients with polycythemia vera ('PV'),who have had an inadequate response to or are intolerant to hydroxyurea. It is also approved for the treatment of patients with intermediate or high-risk myelofibrosis (MF), including primary MF, post-PV MF, and post-essential thrombocythemia MF. The drug is also approved in the United States for treatment of steroid-refractory acute graft-versus-host disease (GVHD) in adult and pediatric patients aged 12 years or older.
Stock Name Country Market Cap PE Ratio
AstraZeneca (AZN) United Kingdom $220.597B 16.47
Amgen (AMGN) United States $158.768B 14.22
Gilead Sciences (GILD) United States $136.384B 14.17
Vertex Pharmaceuticals (VRTX) United States $120.399B 0.00
Bristol Myers Squibb (BMY) United States $95.364B 6.38
GSK (GSK) United Kingdom $78.372B 9.38
CSL (CSLLY) Australia $76.612B 0.00
Regeneron Pharmaceuticals (REGN) United States $61.296B 14.88
Alnylam Pharmaceuticals (ALNY) United States $41.064B 0.00
Argenex SE (ARGX) Netherlands $34.208B 93.37
BioNTech SE (BNTX) Germany $27.138B 0.00
Royalty Pharma (RPRX) United States $20.151B 8.51
Biogen (BIIB) United States $19.666B 8.48
Insmed (INSM) United States $18.626B 0.00
Illumina (ILMN) United States $15.711B 29.80
Genmab (GNMSF) Denmark $14.203B 14.52
Genmab (GMAB) Denmark $13.729B 15.40
Moderna (MRNA) United States $13.010B 0.00
Exelixis (EXEL) United States $12.234B 20.77
BioMarin Pharmaceutical (BMRN) United States $11.142B 18.10
QIAGEN (QGEN) Netherlands $10.699B 20.82
Ascendis Pharma (ASND) Denmark $10.696B 0.00
Swedish Orphan Biovitrum (BIOVF) Sweden $10.413B 26.59
Exact Sciences (EXAS) United States $9.792B 0.00
Verona Pharma American Depositary Share (VRNA) United Kingdom $8.924B 0.00
Bio-Techne Corp (TECH) United States $8.487B 31.66
Blueprint Medicines (BPMC) United States $8.350B 0.00
Roivant Sciences (ROIV) United Kingdom $7.723B 0.00
Repligen (RGEN) United States $7.314B 81.88
Legend Biotech (LEGN) United States $7.159B 0.00
Anbio Biotechnology (NNNN) Germany $7.088B 0.00
Revolution Medicines (RVMD) United States $7.082B 0.00
Halozyme Therapeutics (HALO) United States $7.042B 13.48
Bio-Rad Laboratories (BIO.B) United States $7.014B 24.41
Jazz Pharmaceuticals (JAZZ) Ireland $6.673B 6.55
Guardant Health (GH) United States $6.225B 0.00
TG Therapeutics (TGTX) United States $5.887B 154.52
Nuvalent (NUVL) United States $5.812B 0.00
Rhythm Pharmaceuticals (RYTM) United States $5.516B 0.00
Telix Pharmaceuticals (TLX) Australia $5.404B 0.00
Axsome Therapeutics (AXSM) United States $5.366B 0.00
Alkermes (ALKS) Ireland $4.993B 13.40
CRISPR Therapeutics AG (CRSP) Switzerland $4.905B 0.00
Vaxcyte (PCVX) United States $4.635B 0.00
Cytokinetics (CYTK) United States $4.420B 0.00
ADMA Biologics Inc (ADMA) United States $4.419B 33.05
Krystal Biotech (KRYS) United States $4.282B 33.00
Metsera (MTSR) United States $4.127B 0.00
Akero Therapeutics (AKRO) United States $4.111B 0.00
Zealand Pharma (ZLDPF) Denmark $4.088B 0.00
PTC Therapeutics (PTCT) United States $3.848B 6.70
Arcellx (ACLX) United States $3.801B 0.00
Avidity Biosciences (RNA) United States $3.790B 0.00
Merus (MRUS) Netherlands $3.772B 0.00
Zai Lab (ZLAB) China $3.636B 0.00
Scholar Rock Holding (SRRK) United States $3.555B 0.00
ACADIA Pharmaceuticals (ACAD) United States $3.511B 30.85
Viking Therapeutics (VKTX) United States $3.494B 0.00
Ascentage Pharma Group - (AAPG) China $3.331B 0.00
Protagonist Therapeutics (PTGX) United States $3.285B 70.67
MoonLake Immunotherapeutics (MLTX) Switzerland $3.137B 0.00
Immunovant (IMVT) United States $3.101B 0.00
Kymera Therapeutics (KYMR) United States $2.897B 0.00
HUTCHMED (China) (HCM) Hong Kong, SAR China $2.796B 0.00
Ultragenyx Pharmaceutical (RARE) United States $2.790B 0.00
Mirum Pharmaceuticals (MIRM) United States $2.609B 0.00
Alvotech (ALVO) Luxembourg $2.569B 14.69
Arrowhead Pharmaceuticals (ARWR) United States $2.529B 0.00
ImmunityBio (IBRX) United States $2.480B 0.00
Xenon Pharmaceuticals (XENE) Canada $2.472B 0.00
Apellis Pharmaceuticals (APLS) United States $2.443B 0.00
Ligand Pharmaceuticals (LGND) United States $2.348B 0.00
Twist Bioscience (TWST) United States $2.279B 0.00
Agios Pharmaceuticals (AGIO) United States $2.262B 0.00
Bavarian Nordic (BVNRY) Denmark $2.236B 11.81
Recursion Pharmaceuticals (RXRX) United States $2.146B 0.00
Beam Therapeutics (BEAM) United States $2.128B 0.00
Denali Therapeutics (DNLI) United States $2.109B 0.00
Kiniksa Pharmaceuticals (KNSA) United Kingdom $2.050B 0.00
CG Oncology (CGON) United States $2.037B 0.00
Belite Bio (BLTE) United States $2.013B 0.00
Vericel (VCEL) United States $2.010B 1331.00
Disc Medicine (IRON) United States $1.971B 0.00
IDEAYA Biosciences (IDYA) United States $1.969B 0.00
NovoCure (NVCR) Jersey $1.962B 0.00
Harmony Biosciences Holdings (HRMY) United States $1.952B 12.98
Amicus Therapeutics (FOLD) United States $1.875B 203.00
Certara (CERT) United States $1.799B 33.61
Adaptive Biotechnologies (ADPT) United States $1.796B 0.00
Arcutis Biotherapeutics (ARQT) United States $1.789B 0.00
Sarepta Therapeutics (SRPT) United States $1.786B 0.00
Immunocore Holdings (IMCR) United Kingdom $1.759B 0.00
Apogee Therapeutics (APGE) United States $1.756B 0.00
Tarsus Pharmaceuticals (TARS) United States $1.646B 0.00
89BIO (ETNB) United States $1.606B 0.00
Celldex Therapeutics (CLDX) United States $1.521B 0.00
Vera Therapeutics (VERA) United States $1.519B 0.00
Janux Therapeutics (JANX) United States $1.488B 0.00
GRAIL (GRAL) United States $1.465B 0.00
Travere Therapeutics (TVTX) United States $1.463B 0.00
Edgewise Therapeutics (EWTX) United States $1.456B 0.00
Biohaven (BHVN) United States $1.422B 0.00
Mesoblast (MESO) Australia $1.420B 0.00
ANI Pharmaceuticals (ANIP) United States $1.407B 14.50
Viridian Therapeutics (VRDN) United States $1.390B 0.00
Pharvaris (PHVS) Netherlands $1.314B 0.00
Dynavax Technologies (DVAX) United States $1.270B 75.57
Cogent Biosciences (COGT) United States $1.250B 0.00
CureVac (CVAC) Germany $1.225B 5.93
Liquidia Technologies (LQDA) United States $1.204B 0.00
WAVE Life Sciences (WVE) Singapore $1.198B 0.00
AbCellera Biologics (ABCL) Canada $1.197B 0.00
Intellia Therapeutics (NTLA) United States $1.195B 0.00
MannKind (MNKD) United States $1.146B 23.56
Novavax (NVAX) United States $1.108B 2.58
Structure Therapeutics (GPCR) United States $1.090B 0.00
Pacira BioSciences (PCRX) United States $1.060B 10.09
Praxis Precision Medicines (PRAX) United States $1.029B 0.00
Cidara Therapeutics (CDTX) United States $1.019B 0.00
Arcus Biosciences (RCUS) United States $0.988B 0.00
MiMedx (MDXG) United States $0.984B 23.79
LENZ Therapeutics (LENZ) United States $0.976B 0.00
Nurix Therapeutics (NRIX) United States $0.951B 0.00
Anavex Life Sciences (AVXL) United States $0.948B 0.00
Oric Pharmaceuticals (ORIC) United States $0.946B 0.00
Spyre Therapeutics (SYRE) United States $0.946B 0.00
Mineralys Therapeutics (MLYS) United States $0.944B 0.00
Sana Biotechnology (SANA) United States $0.942B 0.00
NeoGenomics (NEO) United States $0.934B 0.00
Zymeworks (ZYME) United States $0.930B 0.00
BGM Group (BGM) China $0.905B 0.00
Sionna Therapeutics (SION) United States $0.901B 0.00
Niagen Bioscience (NAGE) United States $0.890B 125.56
Replimune (REPL) United States $0.846B 0.00
Geron (GERN) United States $0.841B 0.00
GH Research (GHRS) Ireland $0.826B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.825B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.808B 0.00
UniQure (QURE) Netherlands $0.789B 0.00
Oculis Holding AG (OCS) Switzerland $0.789B 0.00
Vir Biotechnology (VIR) United States $0.781B 0.00
Pharming Group (PHGUF) Netherlands $0.772B 0.00
AnaptysBio (ANAB) United States $0.770B 0.00
Trevi Therapeutics (TRVI) United States $0.768B 0.00
Jyong Biotech (MENS) Taiwan $0.761B 0.00
CorMedix Inc (CRMD) United States $0.761B 51.00
Immunome (IMNM) United States $0.752B 0.00
Nuvation Bio (NUVB) United States $0.749B 0.00
ArriVent BioPharma (AVBP) United States $0.740B 0.00
Immatics (IMTX) Germany $0.726B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.713B 0.00
Gyre Therapeutics (GYRE) United States $0.702B 187.25
Day One Biopharmaceuticals (DAWN) United States $0.688B 0.00
MeiraGTx Holdings (MGTX) United States $0.681B 0.00
Pharming Group (PHAR) Netherlands $0.680B 0.00
Maze Therapeutics (MAZE) United States $0.659B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.657B 0.00
Urogen Pharma (URGN) United States $0.657B 0.00
Stoke Therapeutics (STOK) United States $0.648B 15.01
Dianthus Therapeutics (DNTH) United States $0.645B 0.00
Sinovac Biotech (SVA) China $0.645B 0.00
Tango Therapeutics (TNGX) United States $0.643B 0.00
Phathom Pharmaceuticals (PHAT) United States $0.641B 0.00
Iovance Biotherapeutics (IOVA) United States $0.624B 0.00
Upstream Bio (UPB) United States $0.618B 0.00
Mind Medicine (MindMed) (MNMD) United States $0.609B 0.00
Arbutus Biopharma (ABUS) United States $0.607B 0.00
Keros Therapeutics (KROS) United States $0.586B 0.00
Prime Medicine (PRME) United States $0.585B 0.00
Ginkgo Bioworks Holdings (DNA) United States $0.584B 0.00
Sage Therapeutics (SAGE) United States $0.581B 0.00
Arvinas (ARVN) United States $0.569B 0.00
Castle Biosciences (CSTL) United States $0.568B 38.55
Bicycle Therapeutics (BCYC) United Kingdom $0.554B 0.00
Tyra Biosciences (TYRA) United States $0.545B 0.00
Kura Oncology (KURA) United States $0.544B 0.00
Precigen (PGEN) United States $0.540B 0.00
Rapport Therapeutics (RAPP) United States $0.533B 0.00
Bicara Therapeutics (BCAX) United States $0.530B 0.00
Opthea (OPT) Australia $0.525B 0.00
Abivax SA (ABVX) France $0.525B 0.00
Septerna (SEPN) United States $0.523B 0.00
Celcuity (CELC) United States $0.516B 0.00
Oxford BioMedica (OXBDF) United Kingdom $0.505B 0.00
Myriad Genetics (MYGN) United States $0.492B 0.00
ATyr Pharma (ATYR) United States $0.472B 0.00
Zenas BioPharma (ZBIO) United States $0.468B 0.00
Fortrea Holdings (FTRE) United States $0.462B 12.78
Cullinan Therapeutics (CGEM) United States $0.454B 0.00
Rezolute (RZLT) United States $0.450B 0.00
Kamada (KMDA) Israel $0.446B 26.72
Cytek Biosciences (CTKB) United States $0.437B 0.00
MBX Biosciences (MBX) United States $0.436B 0.00
REGENXBIO (RGNX) United States $0.435B 0.00
Terns Pharmaceuticals (TERN) United States $0.428B 0.00
PureTech Health (PRTC) United States $0.428B 0.00
Fulcrum Therapeutics (FULC) United States $0.423B 0.00
Tectonic Therapeutic (TECX) United States $0.423B 0.00
Erasca (ERAS) United States $0.411B 0.00
Solid Biosciences (SLDB) United States $0.408B 0.00
Emergent Biosolutions (EBS) United States $0.399B 0.00
ITeos Therapeutics (ITOS) United States $0.394B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.390B 0.00
Eton Pharmaceuticals (ETON) United States $0.389B 0.00
Vigil Neuroscience (VIGL) United States $0.384B 0.00
Arcturus Therapeutics Holdings (ARCT) United States $0.374B 0.00
Compass Therapeutics (CMPX) United States $0.373B 0.00
Astria Therapeutics (ATXS) United States $0.359B 0.00
Humacyte (HUMA) United States $0.358B 0.00
Amarin (AMRN) Ireland $0.351B 0.00
Cartesian Therapeutics (RNAC) United States $0.346B 0.00
Prothena (PRTA) Ireland $0.344B 0.00
Absci (ABSI) United States $0.341B 0.00
Benitec Biopharma (BNTC) United States $0.335B 0.00
Ocugen (OCGN) United States $0.333B 0.00
Northwest Biotherapeutics (NWBO) United States $0.332B 0.00
XOMA Royalty (XOMA) United States $0.325B 0.00
Aura Biosciences (AURA) United States $0.322B 0.00
Inventiva S.A (IVA) France $0.320B 0.00
Olema Pharmaceuticals (OLMA) United States $0.318B 0.00
Monte Rosa Therapeutics (GLUE) United States $0.317B 64.50
Rocket Pharmaceuticals (RCKT) United States $0.316B 0.00
Inhibrx Biosciences (INBX) United States $0.315B 0.19
Atea Pharmaceuticals (AVIR) United States $0.314B 0.00
ADC Therapeutics SA (ADCT) Switzerland $0.312B 0.00
Vor Biopharma (VOR) $0.312B 0.00
Gossamer Bio (GOSS) United States $0.309B 0.00
Lifecore Biomedical (LFCR) United States $0.307B 0.00
Neurogene (NGNE) United States $0.306B 0.00
Foghorn Therapeutics (FHTX) United States $0.301B 0.00
DBV Technologies S.A (DBVT) France $0.296B 0.00
Abeona Therapeutics (ABEO) United States $0.294B 0.00
Palvella Therapeutics (PVLA) United States $0.293B 0.00
Candel Therapeutics (CADL) United States $0.291B 0.00
Sagimet Biosciences (SGMT) United States $0.290B 0.00
Annexon (ANNX) United States $0.283B 0.00
Corvus Pharmaceuticals (CRVS) United States $0.282B 0.00
Allogene Therapeutics (ALLO) United States $0.280B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.279B 0.00
Zhengye Biotechnology Holding (ZYBT) China $0.278B 0.00
Cardiff Oncology (CRDF) United States $0.271B 0.00
Aardvark Therapeutics (AARD) United States $0.264B 0.00
Verastem (VSTM) United States $0.257B 0.00
Alpha Teknova (TKNO) United States $0.257B 0.00
Mereo BioPharma Group - (MREO) United Kingdom $0.256B 0.00
Tvardi Therapeutics (TVRD) United States $0.256B 0.00
MiNK Therapeutics (INKT) United States $0.256B 0.00
Crescent Biopharma (CBIO) United States $0.253B 0.00
Entrada Therapeutics (TRDA) United States $0.249B 8.09
Codexis (CDXS) United States $0.248B 0.00
Third Harmonic Bio (THRD) United States $0.246B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.244B 0.00
Adherex Technologies (FENC) United States $0.242B 0.00
Editas Medicine (EDIT) United States $0.241B 0.00
Prima BioMed (IMMP) Australia $0.241B 0.00
Kodiak Sciences (KOD) United States $0.239B 0.00
MaxCyte (MXCT) United States $0.236B 0.00
ScPharmaceuticals (SCPH) United States $0.231B 0.00
Monopar Therapeutics (MNPR) United States $0.225B 0.00
Design Therapeutics (DSGN) United States $0.223B 0.00
Semper Paratus Acquisition (TVGN) United States $0.219B 0.00
Adocia (ADOCY) France $0.216B 0.00
CARGO Therapeutics (CRGX) United States $0.212B 0.00
BioStem Technologies (BSEM) $0.210B 8.52
Neumora Therapeutics (NMRA) United States $0.209B 0.00
AC Immune (ACIU) Switzerland $0.205B 0.00
Eledon Pharmaceuticals (ELDN) United States $0.205B 0.00
Citius Oncology (CTOR) United States $0.202B 0.00
Y-mAbs Therapeutics (YMAB) United States $0.197B 0.00
CytomX Therapeutics (CTMX) United States $0.195B 5.04
Ventyx Biosciences (VTYX) United States $0.195B 0.00
Agenus (AGEN) United States $0.194B 0.00
Voyager Therapeutics (VYGR) United States $0.193B 0.00
Eupraxia Pharmaceuticals (EPRX) Canada $0.193B 0.00
Alumis (ALMS) United States $0.192B 0.00
SELLAS Life Sciences (SLS) United States $0.184B 0.00
GENFIT S.A (GNFT) France $0.183B 0.00
Bright Minds Biosciences (DRUG) United States $0.175B 0.00
Kyverna Therapeutics (KYTX) United States $0.174B 0.00
I-Mab (IMAB) United States $0.174B 0.00
Alpha Cognition (ACOG) Canada $0.173B 0.00
Tiziana Life Sciences (TLSA) United Kingdom $0.173B 0.00
EnGene Holdings (ENGN) Canada $0.169B 0.00
Puma Biotechnology (PBYI) United States $0.168B 4.40
Nuvectis Pharma (NVCT) United States $0.165B 0.00
BioAge Labs (BIOA) United States $0.163B 0.00
Black Diamond Therapeutics (BDTX) United States $0.163B 47.83
Anika Therapeutics (ANIK) United States $0.162B 0.00
Alector (ALEC) United States $0.161B 0.00
Innate Pharma S.A (IPHA) France $0.161B 0.00
Instil Bio (TIL) United States $0.161B 0.00
Immuneering (IMRX) United States $0.159B 0.00
C4 Therapeutics (CCCC) United States $0.158B 0.00
Spero Therapeutics (SPRO) United States $0.157B 0.00
DiaMedica Therapeutics (DMAC) United States $0.156B 0.00
Cuprina Holdings (Cayman) (CUPR) Singapore $0.153B 0.00
Caribou Biosciences (CRBU) United States $0.152B 0.00
Molecular Partners AG (MOLN) Switzerland $0.145B 0.00
Greenwich LifeSciences (GLSI) United States $0.145B 0.00
Theratechnologies (THTX) Canada $0.145B 0.00
Compugen (CGEN) Israel $0.142B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.140B 0.00
Rapt Therapeutics (RAPT) United States $0.140B 0.00
23andMe Holding (MEHCQ) United States $0.136B 0.00
Fate Therapeutics (FATE) United States $0.132B 0.00
Nkarta (NKTX) United States $0.130B 0.00
Genelux (GNLX) United States $0.129B 0.00
Elicio Therapeutics (ELTX) United States $0.129B 0.00
Seer (SEER) United States $0.124B 0.00
Skye Bioscience (SKYE) United States $0.123B 0.00
Actuate Therapeutics (ACTU) United States $0.120B 0.00
BioHarvest Sciences (BHST) Canada $0.118B 0.00
Sangamo Therapeutics (SGMO) United States $0.115B 0.00
Orchestra BioMed Holdings (OBIO) United States $0.112B 0.00
Oncolytics Biotech (ONCY) Canada $0.111B 0.00
Tenaya Therapeutics (TNYA) United States $0.111B 0.00
Seres Therapeutics (MCRB) United States $0.110B 0.00
HilleVax (HLVX) United States $0.105B 0.00
Coya Therapeutics (COYA) United States $0.103B 0.00
TScan Therapeutics (TCRX) United States $0.102B 0.00
Coherus Oncology (CHRS) United States $0.102B 0.00
Contineum Therapeutics (CTNM) United States $0.101B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.101B 0.00
TuHURA Biosciences (HURA) United States $0.100B 0.00
Nautilus Biotechnology (NAUT) United States $0.099B 0.00
Elutia (ELUT) United States $0.098B 0.00
IO Biotech (IOBT) Denmark $0.097B 0.00
Prenetics Global (PRE) Hong Kong, SAR China $0.096B 0.00
Zentalis Pharmaceuticals (ZNTL) United States $0.096B 0.00
OKYO Pharma (OKYO) $0.095B 0.00
BeyondSpring (BYSI) United States $0.093B 0.00
Climb Bio (CLYM) United States $0.093B 0.00
Adagene (ADAG) China $0.090B 0.00
Whitehawk Therapeutics (WHWK) United States $0.090B 0.00
Zura Bio (ZURA) United States $0.090B 0.00
Invivyd (IVVD) United States $0.089B 0.00
Cellectis S.A (CLLS) France $0.088B 0.00
Cabaletta Bio (CABA) United States $0.088B 0.00
Pliant Therapeutics (PLRX) United States $0.087B 0.00
XBiotech (XBIT) United States $0.086B 0.00
Acumen Pharmaceuticals (ABOS) United States $0.085B 0.00
Connect Biopharma Holdings (CNTB) United States $0.084B 0.00
Milestone Pharmaceuticals (MIST) Canada $0.083B 0.00
Quince Therapeutics (QNCX) United States $0.083B 0.00
EXoZymes (EXOZ) United States $0.082B 0.00
IGM Biosciences (IGMS) United States $0.081B 0.00
Immunic (IMUX) United States $0.080B 0.00
TELA Bio (TELA) United States $0.079B 0.00
Entera Bio (ENTX) Israel $0.079B 0.00
Biomea Fusion (BMEA) United States $0.075B 0.00
Immix Biopharma (IMMX) United States $0.074B 0.00
Genenta Science S.p.A (GNTA) Italy $0.072B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.071B 0.00
Alto Neuroscience (ANRO) United States $0.070B 0.00
Oncobiologics (OTLK) United States $0.069B 0.00
Forte Biosciences (FBRX) United States $0.069B 0.00
VistaGen Therapeutics (VTGN) United States $0.069B 0.00
Clearside Biomedical (CLSD) United States $0.069B 0.00
Anebulo Pharmaceuticals (ANEB) United States $0.068B 0.00
ABVC BioPharma (ABVC) United States $0.067B 0.00
Opus Genetics (IRD) United States $0.067B 0.00
Ikena Oncology (IKNA) United States $0.067B 0.00
Repare Therapeutics (RPTX) Canada $0.064B 0.00
Sutro Biopharma (STRO) United States $0.064B 0.00
MediciNova (MNOV) United States $0.062B 0.00
CervoMed (CRVO) United States $0.062B 0.00
Adicet Bio (ACET) United States $0.062B 0.00
Adlai Nortye (ANL) Cayman Islands $0.059B 0.00
InflaRx (IFRX) Germany $0.059B 0.00
Earth Science Tech (ETST) United States $0.059B 0.00
Applied Therapeutics (APLT) United States $0.059B 0.00
Cue Biopharma (CUE) United States $0.058B 0.00
PDS Biotechnology (PDSB) United States $0.057B 0.00
Fortress Biotech (FBIO) United States $0.056B 0.00
Senti Biosciences (SNTI) United States $0.056B 0.00
Atara Biotherapeutics (ATRA) United States $0.055B 0.00
INmune Bio (INMB) United States $0.054B 0.00
VTv Therapeutics (VTVT) United States $0.054B 0.00
Quantum Biopharma (QNTM) Canada $0.054B 0.00
Werewolf Therapeutics (HOWL) United States $0.053B 0.00
Adverum Biotechnologies (ADVM) United States $0.053B 0.00
Annovis Bio (ANVS) United States $0.053B 0.00
Jasper Therapeutics (JSPR) United States $0.053B 0.00
ZIVO Bioscience (ZIVO) United States $0.051B 0.00
Aligos Therapeutics (ALGS) United States $0.051B 0.00
Celularity (CELU) United States $0.051B 0.00
Inovio Pharmaceuticals (INO) United States $0.050B 0.00
Artiva Biotherapeutics (ARTV) United States $0.050B 0.00
Precision BioSciences (DTIL) United States $0.049B 0.00
Grace Therapeutics (GRCE) Canada $0.048B 0.00
RenovoRx (RNXT) United States $0.047B 0.00
Renovaro (RENB) United States $0.046B 0.00
Exicure (XCUR) United States $0.046B 0.00
Kalaris Therapeutics (KLRS) United States $0.045B 0.00
Scilex Holding (SCLX) United States $0.045B 0.00
Mersana Therapeutics (MRSN) United States $0.043B 0.00
Pluri (PLUR) Israel $0.042B 0.00
PepGen (PEPG) United States $0.041B 0.00
Medicus Pharma (MDCX) United States $0.041B 0.00
Alterity Therapeutics - (ATHE) Australia $0.041B 0.00
Barinthus Biotherapeutics (BRNS) United Kingdom $0.040B 0.00
Lantern Pharma (LTRN) United States $0.040B 0.00
Shattuck Labs (STTK) United States $0.039B 0.00
Hyperion DeFi (HYPD) United States $0.038B 0.00
Xilio Therapeutics (XLO) United States $0.038B 0.00
KALA BIO (KALA) United States $0.038B 0.00
Rani Therapeutics Holdings (RANI) United States $0.037B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.036B 0.00
LAVA Therapeutics (LVTX) Netherlands $0.036B 0.00
Cognition Therapeutics (CGTX) United States $0.035B 0.00
OnKure Therapeutics (OKUR) United States $0.034B 0.00
Coeptis Therapeutics Holdings (COEP) United States $0.033B 0.00
Kezar Life Sciences (KZR) United States $0.033B 0.00
Radiopharm Theranostics - (RADX) Australia $0.033B 0.00
Q32 Bio (QTTB) United States $0.032B 0.00
AN2 Therapeutics (ANTX) United States $0.032B 0.00
Biodexa Pharmaceuticals (BDRX) United Kingdom $0.032B 0.00
Rein Therapeutics (RNTX) United States $0.032B 0.00
Estrella Immunopharma (ESLA) United States $0.032B 0.00
CAMP4 Therapeutics (CAMP) United States $0.030B 0.00
Femasys (FEMY) United States $0.030B 0.00
Dyadic (DYAI) United States $0.030B 0.00
Clene (CLNN) United States $0.030B 0.00
Ovid Therapeutics (OVID) United States $0.029B 0.00
NeuroSense Therapeutics (NRSN) Israel $0.028B 0.00
CalciMedica (CALC) United States $0.028B 0.00
Boundless Bio (BOLD) United States $0.027B 0.00
Generation Bio (GBIO) United States $0.026B 0.00
ALX Oncology Holdings (ALXO) United States $0.026B 0.00
Cadrenal Therapeutics (CVKD) United States $0.025B 0.00
Passage Bio (PASG) United States $0.025B 0.00
FibroBiologics (FBLG) United States $0.025B 0.00
SAB Biotherapeutics (SABS) United States $0.024B 0.00
Tenax Therapeutics (TENX) United States $0.024B 0.00
Lisata Therapeutics (LSTA) United States $0.023B 0.00
BioAtla (BCAB) United States $0.022B 0.00
Elevation Oncology (ELEV) United States $0.022B 0.00
Dare Bioscience (DARE) United States $0.022B 0.00
Chemomab Therapeutics (CMMB) Israel $0.022B 0.00
MIRA Pharmaceuticals (MIRA) United States $0.022B 0.00
Longeveron (LGVN) United States $0.021B 0.00
Aytu BioPharma (AYTU) United States $0.020B 0.00
Curis (CRIS) United States $0.019B 0.00
Hoth Therapeutics (HOTH) United States $0.019B 0.00
Cingulate (CING) United States $0.018B 0.00
CollPlant Biotechnologies (CLGN) Israel $0.018B 0.00
Gelteq (GELS) Australia $0.017B 0.00
Athira Pharma (ATHA) United States $0.017B 0.00
Rallybio (RLYB) United States $0.017B 0.00
Sonnet BioTherapeutics Holdings (SONN) United States $0.016B 0.00
Aspire Biopharma Holdings (ASBP) United States $0.016B 0.00
Advanced Biomed (ADVB) United States $0.016B 0.00
Lexaria Bioscience (LEXX) Canada $0.015B 0.00
Allarity Therapeutics (ALLR) United States $0.015B 0.00
Beyond Air (XAIR) United States $0.015B 0.00
Edesa Biotech (EDSA) Canada $0.015B 0.00
HOOKIPA Pharma (HOOK) United States $0.015B 0.00
Neuphoria Therapeutics (NEUP) Australia $0.014B 0.00
Synlogic (SYBX) United States $0.014B 0.00
MetaVia (MTVA) United States $0.014B 0.00
Acurx Pharmaceuticals (ACXP) United States $0.014B 0.00
BRIACELL THERAP (BCTX) Canada $0.014B 0.00
Leap Therapeutics (LPTX) United States $0.014B 0.00
IBio (IBIO) United States $0.013B 0.00
BioCardia (BCDA) United States $0.013B 0.00
Artelo Biosciences (ARTL) United States $0.013B 0.00
Promis Neurosciences (PMN) Canada $0.013B 0.00
Abpro Holdings (ABP) United States $0.013B 0.00
Equillium (EQ) United States $0.013B 0.00
Synaptogenix (TAOX) United States $0.012B 0.00
Biorestorative Therapies (BRTX) United States $0.012B 0.00
BioXcel Therapeutics (BTAI) United States $0.012B 0.00
Bolt Biotherapeutics (BOLT) United States $0.012B 0.00
Brainstorm Cell Therapeutics (BCLI) United States $0.012B 0.00
Cyclerion Therapeutics (CYCN) United States $0.012B 0.00
Mustang Bio (MBIO) United States $0.012B 0.00
Bionano Genomics (BNGO) United States $0.011B 0.00
COSCIENS Biopharma (CSCI) Canada $0.011B 0.00
NextCure (NXTC) United States $0.011B 0.00
Novogen (KZIA) Australia $0.011B 0.00
GeoVax Labs (GOVX) United States $0.011B 0.00
Lixte Biotechnology Holdings (LIXT) United States $0.011B 0.00
Imunon (IMNN) United States $0.011B 0.00
Sensei Biotherapeutics (SNSE) United States $0.010B 0.00
IMMURON (IMRN) Australia $0.010B 0.00
Aprea Therapeutics (APRE) United States $0.010B 0.00
GENPREX (GNPX) United States $0.009B 0.00
Dogwood Therapeutics (DWTX) United States $0.009B 0.00
BioAffinity Technologies (BIAF) United States $0.009B 0.00
Turnstone Biologics (TSBX) United States $0.009B 0.00
Intensity Therapeutics (INTS) United States $0.008B 0.00
X4 Pharmaceuticals (XFOR) United States $0.008B 0.00
Jade Biosciences (JBIO) United States $0.008B 0.00
Biofrontera (BFRI) United States $0.008B 0.00
Moleculin Biotech (MBRX) United States $0.008B 0.00
Creative Medical Technology Holdings (CELZ) United States $0.008B 0.00
Evogene (EVGN) Israel $0.007B 0.00
GT Biopharma (GTBP) United States $0.007B 0.00
Cardio Diagnostics Holdings (CDIO) United States $0.007B 0.00
Sunshine Biopharma (SBFM) United States $0.007B 0.00
IN8bio (INAB) United States $0.007B 0.00
Silexion Therapeutics Corp (SLXN) Israel $0.007B 0.00
Mainz Biomed (MYNZ) Germany $0.007B 0.00
Arcadia Biosciences (RKDA) United States $0.007B 0.00
Portage Biotech (PRTG) $0.006B 0.00
HCW Biologics (HCWB) United States $0.006B 0.00
Apollomics (APLM) United States $0.006B 0.00
Cyclacel Pharmaceuticals (CYCC) $0.006B 0.00
180 Life Sciences (ATNF) United States $0.005B 0.00
Pasithea Therapeutics (KTTA) United States $0.005B 0.00
Ensysce Biosciences (ENSC) United States $0.005B 0.00
VivoSim Labs (VIVS) United States $0.005B 0.00
Avalon GloboCare (ALBT) United States $0.005B 0.00
CNS Pharmaceuticals (CNSP) United States $0.005B 0.00
Galecto (GLTO) Denmark $0.005B 0.00
Tharimmune (THAR) United States $0.005B 0.00
Dermata Therapeutics (DRMA) United States $0.005B 0.00
Revelation Biosciences (REVB) United States $0.004B 0.00
Soligenix (SNGX) United States $0.004B 0.00
Adial Pharmaceuticals (ADIL) United States $0.004B 0.00
Titan Pharmaceuticals (TTNP) United States $0.004B 0.00
Virax Biolabs Group (VRAX) United Kingdom $0.004B 0.00
Polyrizon (PLRZ) Israel $0.004B 0.00
Palisade Bio (PALI) United States $0.004B 0.00
GRI Bio (GRI) United States $0.004B 0.00
Enveric Biosciences (ENVB) United States $0.003B 0.00
Purple Biotech (PPBT) Israel $0.003B 0.00
AquaBounty Technologies (AQB) United States $0.003B 0.00
Psyence Biomedical (PBM) Canada $0.003B 0.00
ZyVersa Therapeutics (ZVSA) United States $0.003B 0.00
Windtree Therapeutics (WINT) United States $0.003B 0.00
Silo Pharma (SILO) United States $0.003B 0.00
Alzamend Neuro (ALZN) United States $0.003B 0.00
Entero Therapeutics (ENTO) United States $0.002B 0.00
Scinai Immunotherapeutics (SCNI) Israel $0.002B 0.00
Aptevo Therapeutics (APVO) United States $0.002B 0.00
Onconetix (ONCO) United States $0.002B 0.00
Atrinsic (PTIX) United States $0.002B 0.00
Bone Biologics (BBLG) United States $0.002B 0.00
NuCana (NCNA) United Kingdom $0.000B 0.00
Aceragen (ACGN) United States $0.000B 0.00
ARAVIVE, INC (ARAV) United States $0.000B 0.00
Clovis Oncology (CLVSQ) United States $0.000B 0.00
Cocrystal Pharma (COCP) United States $0.000B 0.00
Celyad SA (CYAD) Belgium $0.000B 0.00
CytoMed Therapeutics (GDTC) Singapore $0.000B 0.00
Galapagos (GLPG) Belgium $0.000B 0.00
LakeShore Biopharma (LSB) China $0.000B 0.00
Motif Bio Plc (MTFB) United Kingdom $0.000B 0.00
PDL BioPharma (PDLI) United States $0.000B 0.00
Pulmatrix (PULM) United States $0.000B 0.00
Regencell Bioscience Holdings (RGC) Hong Kong, SAR China $0.000B 0.00
TFF Pharmaceuticals (TFFP) United States $0.000B 0.00
VectivBio Holding AG (VECT) Switzerland $0.000B 0.00